lundi 21 octobre 2019

Risque de fausse couche

Risque de fausse couche

The drug, raloxifene , modulates the activity of the hormone estrogen. The finding was published in the April 20issue of the American Journal . Indications, side effects, contraindications and other prescribing information for Raloxifene on MIMS. Evista is used to treat and prevent osteoporosis in postmenopausal women. Raloxifene is a selective estrogen receptor modulator (with mixed agonist and antagonist activity) approved for the treatment of osteoporosis in . Le tamoxifène et le raloxifène réduisent le cancer invasif du sein ; aucun ne réduit les taux de mortalité dans le groupe en particulier. Nelson H, B Smith, Griffin J, . PI CMI Trade Names and Active Ingredients containing raloxifene.


Risque de fausse couche

Need more information on a product? Search the Australian . Raloxifene (Ral) (see Fig. 1) is a polyhydroxyphenyl benzothiophene antiestrogen that has low estrogen agonist activity in the rodent uterus . EVISTA ( raloxifene hydrochloride) Tablet for Oral Use. WARNING: INCREASED RISK OF VENOUS THROMBOEMBOLISM.


The active ingredient in Evista tablets is raloxifene hydrochloride.

Aucun commentaire:

Enregistrer un commentaire

Remarque : Seul un membre de ce blog est autorisé à enregistrer un commentaire.

Articles les plus consultés